483
Boston Scientific CorporationFDA 483 - Boston Scientific Corporation - November 16, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Boston Scientific Corporation in Maple Grove, MN, identified significant issues in the management of an investigational clinical study. The firm's PMA Clinical Study Report records were found to be inaccurate and incomplete, with numerous unreported safety events and protocol deviations. Furthermore, proper monitoring of clinical study sites was not ensured, leading to unaddressed non-compliances and a failure to secure investigator compliance.
Open in Dashboard
ID · a4dcdaf7-9727-41af-b03e-b1a4a97f7265